Such events included transient neutropenia, an elevation of lipid parameters or liver enzymes (> 1 to 3 x ULN, leading to a reduction of the TCZ dose to 4 mg/kg until normalization of ALT or AST in 6 patients), and non-serious infections. The gene discussed is GPT; the disease is infection.